New blood test could spot ovarian cancer type before surgery
NCT ID NCT06709872
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to improve how doctors tell the difference between borderline ovarian tumors and early-stage invasive ovarian cancer before surgery. Researchers will test a panel of nine blood-based biomarkers in 400 women with suspicious ovarian cysts. If successful, this could lead to more accurate diagnoses and better treatment decisions without needing immediate surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE OVARIAN TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Faculty Hospital of the Charles University
RECRUITINGPrague, Czechia
-
Istituto Nazionale dei Tumore
NOT_YET_RECRUITINGMilan, Italy
-
UZ Leuven
RECRUITINGLeuven, Flemish Brabant, 3000, Belgium
-
Università Cattolica del Sacro Cuore
NOT_YET_RECRUITINGRome, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.